Skip to main content
Livermore
Livermore
ZHEN

Ossiam

SEC CIK
0001767471
Latest filing
Aug 13, 2026

BMRN holding history

Biomarin Pharmaceutical Inc in every 13F filed by Ossiam, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

BMRN overviewAll 13F holders of BMRNFull Q2 2026 holdings

Shares (Q2 2026)
40,357
Value
$2.31M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of BMRN by Ossiam, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202640,357$2.31M<0.1%+18,528+84.9%AddedHolders
Q1 202621,829$1.23M<0.1%+10,163+87.1%AddedHolders
Q4 202511,666$693.3K<0.1%−5,791−33.2%ReducedHolders
Q3 202517,457$945.5K<0.1%+17,249+8,292.8%AddedHolders
Q2 2025208$11.4K<0.1%00.0%UnchangedHolders
Q1 2025208$14.7K<0.1%−268−56.3%ReducedHolders
Q4 2024476$31.3K<0.1%−2,369−83.3%ReducedHolders
Q3 20242,845$200.0K<0.1%−121−4.1%ReducedHolders
Q2 20242,966$244.2K<0.1%+5+0.2%AddedHolders
Q1 20242,961$258.6K<0.1%−1,704−36.5%ReducedHolders
Q4 20234,665$449.8K<0.1%+1,946+71.6%AddedHolders
Q3 20232,719$240.6K<0.1%−52−1.9%ReducedHolders
Q2 20232,771$240.2K<0.1%+1,287+86.7%AddedHolders
Q1 20231,484$144.3K<0.1%−5,597−79.0%ReducedHolders
Q4 20227,081$732.8K<0.1%+2,620+58.7%AddedHolders
Q3 20224,461$378.0K<0.1%−1,302−22.6%ReducedHolders
Q2 20225,763$478.0K<0.1%+1,559+37.1%AddedHolders
Q1 20224,204$324.0K<0.1%+1,866+79.8%AddedHolders
Q4 20212,338$207.0K<0.1%−719−23.5%ReducedHolders
Q3 20213,057$236.0K<0.1%00.0%UnchangedHolders
Q2 20213,057$235.0K<0.1%+1,588+108.1%AddedHolders
Q1 20211,469$111.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.